Impact of the Extended Thrombolysis Time Window on the Proportion of Recombinant Tissue-Type Plasminogen Activator-Treated Stroke Patients and on Door-to-Needle Time
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.